ENTA
Enanta Pharmaceuticals Inc
Price:  
11.39 
USD
Volume:  
134,401.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA WACC - Weighted Average Cost of Capital

The WACC of Enanta Pharmaceuticals Inc (ENTA) is 7.9%.

The Cost of Equity of Enanta Pharmaceuticals Inc (ENTA) is 7.90%.
The Cost of Debt of Enanta Pharmaceuticals Inc (ENTA) is 5.00%.

Range Selected
Cost of equity 6.40% - 9.40% 7.90%
Tax rate 2.00% - 2.50% 2.25%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 9.3% 7.9%
WACC

ENTA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.8
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 9.40%
Tax rate 2.00% 2.50%
Debt/Equity ratio 0.01 0.01
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 9.3%
Selected WACC 7.9%